contractor articles (500)
Active Articles:
A53024: Billing and Coding: JW Modifier Billing GuidelinesA53026: Billing and Coding: Bariatric Surgery Coverage
A53032: Self-Administered Drug Exclusion List:
A53287: High Compression Bandage System Clarification
A53289: Therapy Driving Evaluations
A53304: Billing and Coding: Medical Necessity of Therapy Services
A53309: Billing and Coding: Therapy Evaluation, Re-Evaluation and Formal Testing
A53352: Billing and Coding: Outpatient Therapy Biofeedback Training
A54068: Outpatient Cardiac Rehabilitation
A54356: Billing and Coding: MolDX: Afirma™ Assay by Veracyte
A54376: Billing and Coding: MolDX: Avise PG Assay
A54386: Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID®
A54445: Billing and Coding: MolDX: MammaPrint
A54480: Billing and Coding: MolDX: Oncotype DX® Breast Cancer Assay
A54484: Billing and Coding: MolDX: Oncotype DX® Colon Cancer
A54489: Billing and Coding: MolDX: Progensa® PCA3 Assay
A54494: Billing and Coding: MolDx: ResponseDX Tissue of Origin®
A54503: Billing and Coding: MolDX: Vectra™ DA
A54543: Therapeutic Apheresis for Familial Hypercholesterolemia
A54547: Response to Comments: MolDX: Molecular Diagnostic Tests (MDT)
A54589: Response to Comments: MolDX: Prolaris Prostate Cancer Genomic Assay, L36340
A54594: Response to Comments: Special Histochemical Stains and Immunohistochemical Stains, L36346
A54630: Response to Comments: MolDX: Decipher Prostate Cancer Classifier Assay
A54644: Response to Comments: Immune Globulin Intravenous (IVIg)
A54710: Response to Comments: Treatment of Varicose Veins of Lower Extremities
A54865: Response to Comments: MolDX: Molecular RBC Phenotyping
A54882: Response to Comments: MolDX - CDD: NSCLC, Comprehensive Genomic Profile Testing Response to Comments
A54893: Response to Comments: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia
A54895: Response to Comments: MolDX: MGMT Promoter Methylation Analysis
A54897: Response to Comments: MolDX: BRCA1 and BRCA 2 Genetic Testing
A54919: Investigational Device Exemptions (IDE) - IDE Documentation Requirements for Studies with an FDA Approval dated January 01, 2015 or later
A54927: Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
A54964: Response to Comments: MolDX: Genetic Testing for Lynch Syndrome
A54969: Billing and Coding: Nerve Conduction Studies and Electromyography
A54978: Response to Comments: MolDX: Biomarkers in Cardiovascular Risk Assessment
A54980: Response to Comments: Spinal Cord Stimulators for Chronic Pain
A54990: Response to Comments: Nerve Conduction Studies and Electromyography
A54995: Billing and Coding: MolDX: Genetic Testing for Lynch Syndrome
A54998: Response to Comments: Controlled Substance Monitoring and Drugs of Abuse Testing Comment Period Ending 05/02/2014.
A55001: Billing and Coding: Lab: Controlled Substance Monitoring and Drugs of Abuse Testing
A55033: Response to Comments: MolDX-CDD: Genomic Health™ Oncotype DX® Prostate Cancer Assay
A55044: Billing and Coding: Patients Supplied Donated or Free-of-Charge Drug
A55048: Response to Comments: MolDX: NRAS Genetic Testing
A55053: Response to Comments: Treatment of Males with Low Testosterone
A55058: Waiver of Face-to-Face Visit for Home Dialysis Patients
A55072: Response to Comments: Total Hip Arthroplasty
A55079: Response to Comments: Total Knee Arthroplasty
A55080: Response to Comments: MolDX: Chromosome 1p/19q Deletion Analysis
A55085: Billing and Coding: MolDX: CHD7 Gene Analysis
A55088: Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency (ASPA) Testing
A55090: Billing and Coding: MolDX: 4q25-AF Risk Genotype
A55092: Billing and Coding: MolDX: 9p21 Genotype Test
A55094: Billing and Coding: MolDX: ApoE Genotype
A55097: Billing and Coding: MolDX: ATP7B Gene Tests
A55099: Billing and Coding: MolDX: BCKDHB Gene Test
A55113: Billing and Coding: MolDX: BLM Gene Analysis
A55115: Billing and Coding: MolDX: BluePrint® Test
A55154: Response to Comments: Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs)
A55181: Billing and Coding: MolDX: ENG and ACVRL1 Gene Tests
A55183: Billing and Coding: MolDX: FANCC Genetic Testing
A55239: Billing and Coding: Implantable Infusion Pumps for Chronic Pain
A55241: Billing and Coding: MolDX: Fragile X
A55243: Billing and Coding: MolDX: GBA Genetic Testing
A55249: Billing and Coding: MolDX: HAX1 Gene Sequencing
A55253: Billing and Coding: MolDX: HBB Gene Tests
A55255: Billing and Coding: MolDX: HEXA Gene Analysis
A55264: Billing and Coding: MolDX: HTTLPR Gene Testing
A55272: Billing and Coding: MolDX: KIF6 Genotype
A55274: Billing and Coding: MolDX: Know error®
A55277: Billing and Coding: MolDX: L1CAM Gene Sequencing
A55279: Billing and Coding: MolDX: LPA-Aspirin Genotype
A55281: Billing and Coding: MolDX: LPA-Intron 25 Genotype
A55283: Billing and Coding: MolDX: MCOLN1 Genetic Testing
A55285: Billing and Coding: MolDX: MECP2 Genetic Testing
A55288: Billing and Coding: MolDX: MMACHC Test
A55290: Billing and Coding: MolDX: Mitochondrial Nuclear Gene Tests
A55292: Billing and Coding: MolDX: myPap™
A55294: Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx®
A55361: Response to Comments: Serum Magnesium
A55372: Response to Comments: Vitamin D Assay Testing
A55383: Response to Comments: Botulinum Toxin Types A and B
A55457: Response to Comments: Bladder/Urothelial Tumor Markers
A55463: Response to Comments: MolDX: APC and MUTYH Gene Testing
A55468: Billing and Coding: MolDX: VEGFR2 Tests
A55470: Response to Comments: MolDX- CDD: ProMark Risk Score
A55472: Response to Comments: Trigger Point Injections
A55480: Billing and Coding: MolDX: STAT3 Gene Testing
A55484: Billing and Coding: MolDX: TP53 Gene Tests
A55489: Response to Comments: Injections - Tendon, Ligament, Ganglion Cyst, Tunnel Syndromes and Morton's Neuroma
A55491: Response to Comments: Polysomnography and Other Sleep Studies
A55503: Skilled Therapy Services in the SNF PPS Setting
A55527: Response to Comments: GlycoMark Testing for Glycemic Control
A55530: Billing and Coding: Peripheral Nerve Stimulation
A55553: Response to Comments: Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography
A55555: Response to Comments: Diagnostic and Therapeutic Colonoscopy
A55593: Billing and Coding: MolDX: OncoCee™
A55594: Billing and Coding: MolDX: PreDx®
A55595: Billing and Coding: MolDX: BCR-ABL
A55596: Billing and Coding: MolDX: SULT4A1 Genetic Testing
A55608: Billing and Coding: MolDX: PTCH1 Gene Testing
A55611: Billing and Coding: MolDX: TERC Gene Tests
A55612: Billing and Coding: MolDX: IKBKAP Genetic Testing
A55623: Billing and Coding: MolDX: SEPT9 Gene Test
A55624: Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Next-Generation Sequencing Testing in Cancer
A55625: Billing and Coding: MolDX: PAX6 Gene Sequencing
A55653: Parenteral Iron Administration Coverage in Non-Dialysis Usage
A55657: Response to Comments: MolDX DecisionDX Uveal Melanoma
A55661: Response to Comments: MolDX: Xpresys Lung
A55665: Response to Comments: MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease
A55675: Billing and Coding: Frequency of Hemodialysis
A55684: Response to Comments: Plastic Surgery
A55688: Response to Comments: Cataract Surgery in Adults
A55754: Home PT/INR Monitoring (G0249) Billing and Coding
A55760: Response to Comments: MolDX: AlloSure® Donor-Derived Cell-Free DNA Test
A55769: Billing and Coding: Lab: Coenzyme Q10 (CoQ10)
A55778: Response to Comments: MolDX: Prometheus IBD sgi Diagnostic Policy
A55793: Response to Comments: MolDX: EndoPredict® Breast Cancer Gene Expression Test
A55839: Response to Comments: MolDX: Oncotype DX® Genomic Prostate Score for Men with Favorable Intermediate Risk Prostate Cancer
A55881: Billing and Coding: MolDX: ThermoFisher Oncomine Dx Target Test For Non-Small Cell Lung Cancer
A55902: Response to Comments: Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder
A55936: Response to Comments: Chest X-Ray Policy
A55970: Billing and Coding: MolDX: CDH1 Genetic Testing
A55984: Response to Comments: Respiratory Care (Respiratory Therapy)
A56009: Billing and Coding: MolDX: FDA Approved CLL Companion Diagnostic Test
A56017: Response to Comments: Lumbar MRI
A56034: Billing and Coding: Nerve Blockade for Treatment of Chronic Pain and Neuropathy
A56041: Response to Comments: Peripheral Nerve Stimulation
A56061: Response to Comments: MRI and CT Scans of Head and Neck
A56076: Response to Comments: In Vitro Chemosensitivity & Chemoresistance Assays
A56091: Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
A56112: Non-Payment for Prefabricated Splints
A56155: Use of Amniotic Membrane Derived Skin Substitutes
A56191: Response to Comments: 4Kscore Assay
A56205: Response to Comments: MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs)
A56211: Response to Comments: MolDX: Cystatin C Measurement
A56228: Response to Comments: MolDX: Corus® CAD Assay
A56230: Response to Comments: MolDX: DecisionDx-Melanoma
A56240: Response to Comments: Frequency of Hemodialysis
A56251: Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels
A56253: Response to Comments: Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor
A56256: Response to Comments: MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)
A56322: Billing and Coding: MolDX: clonoSEQ® Assay for Assessment of Minimal Residual Disease (MRD) in Patients with Specific Lymphoid Malignancies
A56340: Billing and Coding: Implantable Automatic Defibrillators
A56356: Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test
A56361: Response to Comments: MolDX: Genetic Testing for Lynch Syndrome
A56375: Response to Comments: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test
A56381: Response to Comments: Helicobacter Pylori Infection Testing
A56387: Response to Comments: MolDX: myPath Melanoma Assay
A56411: Response to Comments: MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer
A56436: Response to Comments: MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Very Low and Low Risk Disease
A56446: Response to Comments: MolDX: MDS FISH
A56514: Billing and Coding: Mohs Micrographic Surgery
A56572: Billing and Coding: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
A56706: Billing and Coding: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs)
A57079: Billing and Coding: Injections - Tendon, Ligament, Ganglion Cyst, Tunnel Syndromes and Morton's Neuroma
A57083: Billing and Coding: B-type Natriuretic Peptide (BNP) Testing
A57161: Billing and Coding: Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs)
A57183: Billing and Coding: Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography
A57185: Billing and Coding: Botulinum Toxin Types A and B Policy
A57187: Billing and Coding: Immune Globulin Intravenous (IVIg)
A57189: Billing and Coding: Serum Magnesium
A57190: Billing and Coding: Blepharoplasty, Eyelid Surgery, and Brow Lift
A57195: Billing and Coding: Cataract Surgery in Adults
A57202: Billing and Coding: Lumbar Epidural Injections
A57204: Billing and Coding: MRI and CT Scans of the Head and Neck
A57206: Billing and Coding: Lumbar MRI
A57268: Billing and Coding: MolDX: Melanoma Risk Stratification Molecular Testing
A57287: Billing and Coding: MolDX: Androgen Receptor Variant (AR-V7) Protein Test
A57326: Billing and Coding: Electrocardiograms
A57329: Billing and Coding: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
A57331: Billing and Coding: MolDX: Repeat Germline Testing
A57342: Billing and Coding: Diagnostic and Therapeutic Colonoscopy
A57354: Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing
A57356: Billing and Coding: MolDX: BDX-XL2
A57372: Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
A57380: Billing and Coding: MolDX: AlloSure® or Equivalent Cell-Free DNA Testing for Kidney and Heart Allografts
A57417: Billing and Coding: MolDX: DecisionDx-Melanoma
A57419: Billing and Coding: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test
A57421: Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
A57432: Billing and Coding: MolDX: MGMT Promoter Methylation Analysis
A57441: Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
A57459: Billing and Coding: Treatment of Ulcers & Symptomatic Hyperkeratoses
A57497: Billing and Coding: Chest X-Ray Policy
A57502: Billing and Coding: MolDX: Percepta© Bronchial Genomic Classifier
A57512: Billing and Coding: Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor
A57514: Billing and Coding: MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease
A57523: Billing and Coding: MolDX: Immunohistochemistry (IHC) Indications for Breast Pathology
A57526: Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)
A57607: Billing and Coding: MolDX: EndoPredict® Breast Cancer Gene Expression Test
A57612: Billing and Coding: Measurement of Salivary Hormones
A57615: Billing and Coding: Treatment of Males with Low Testosterone
A57619: Billing and Coding: MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
A57643: Billing and Coding: MolDX: Cystatin C Measurement
A57664: Billing and Coding: MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer
A57683: Billing and Coding: Total Hip Arthroplasty
A57685: Billing and Coding: Total Knee Arthroplasty
A57689: Billing and Coding: Lab: Flow Cytometry
A57692: Billing and Coding: Repetitive Transcranial Magnetic Stimulation (rTMS) in Adults with Treatment Resistant Major Depressive Disorder
A57697: Billing and Coding: Polysomnography and Other Sleep Studies
A57701: Billing and Coding: Trigger Point Injections
A57706: Billing and Coding: Treatment of Varicose Veins of the Lower Extremities
A57718: Billing and Coding: Vitamin D Assay Testing
A57727: Billing and Coding: Facet Joint Injections, Medial Branch Blocks, and Facet Joint Radiofrequency Neurotomy
A57744: Response to Comments: MolDX: TruGraf Blood Gene Expression Test
A57746: Billing and Coding: MolDX: Trugraf Blood Gene Expression Test
A57773: Billing and Coding: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test
A57791: Billing and Coding: Spinal Cord Stimulators for Chronic Pain
A57815: Billing and Coding: MolDX: Circulating Tumor Cell Marker Assays
A57818: Response to Comments: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
A57848: Billing and Coding: Tomosynthesis-Guided Breast Biopsy
A57863: Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS)
A57891: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
A57894: Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
A57901: Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors
A57904: Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors
A57907: Response to Comments: Micro-Invasive Glaucoma Surgery (MIGS)
A57938: Response to Comments: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
A57948: Billing and Coding: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
A57954: Billing and Coding: Routine Foot Care
A57970: Billing and Coding: MolDX: HLA Testing for Transplant Histocompatibility
A57988: Response to Comments: MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Intermediate Risk Disease
A58052: Billing and Coding: MolDX: Pigmented Lesion Assay
A58072: Response to Comments: MolDX Pigmented Lesion Assay
A58120: Billing and Coding: MolDX: Testing of Multiple Genes
A58133: Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM)
A58176: Response to Comments: MolDX: Repeat Germline Testing
A58223: Billing and Coding: Computed Tomography Cerebral Perfusion Analysis (CTP)
A58227: Billing and Coding: Transurethral Waterjet Ablation of the Prostate
A58236: Billing and Coding: Intensity Modulated Radiation Therapy (IMRT)
A58237: Response to Comments: MolDX: Pharmacogenomics Testing
A58271: Response to Comments: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
A58307: Billing and Coding: Platelet Rich Plasma
A58340: Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)
A58448: Billing and Coding: MolDX: Minimal Residual Disease Testing for Colorectal Cancer
A58481: Response to Comments: MolDX: AlloSure® or Equivalent Cell-Free DNA Testing for Kidney and Heart Allografts
A58505: Response to Comments: MolDX: Blood Product Molecular Antigen Typing
A58507: Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing
A58509: Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
A58516: Response to Comments: MolDX: Androgen Receptor Variant (AR-V7) Protein Test
A58520: Response to Comments: Computed Tomography Cerebral Perfusion Analysis (CTP)
A58522: Response to Comments: Transurethral Waterjet Ablation of the Prostate
A58534: Response to Comments: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)